DZS Software to Demonstrate (CTMS) at upcoming ACRP Conference
Posted on Wed, Mar 31, 2010
ClinPlus's CTMS system now available in a software-as-a-service (SaaS) delivery model, offering CRO's, Pharma, Biotech and Medical Device organizations cost-effective subscription model pricing, rapid system deployment, scalability, and site set-up flexibility.
Bound Brook, NJ - March 31, 2010 - DZS Software Solutions, Inc. plans on demonstrating enhanced functionality for its recently released (June 2009) CTMS software solution, part of the ClinPlus Solution Suite at the upcoming ACRP Global Conference in Tampa, FL, April 23rd - 27th. (Booth # 529)
In today's competitive drug development environment, two glaring statistics point to a major obstacle in shortening time-to-market and lowering the cost of clinical trials. First, almost half of the cost of bringing a new drug or device to market, or close to $400 million, is accrued during the clinical trial phase. Second, recent studies also indicate that 75 percent of all trials conducted in the United States are behind schedule by one to six months.
Most of these clinical trials involve a large amount of data, both paper-based and electronic, from thousands of patients, hundreds of sites and a multitude of trial administrators - data that must be collected, transmitted, shared, analyzed, and archived. The good news is that with products like ClinPlus CTMS, companies can reap significant cost and time savings with better visibility and efficient management of their clinical trial information.
The availability of ClinPlus CTMS in a SaaS delivery model is also an extremely important and timely development for many emerging Life Science organizations struggling with the challenges of improving clinical trial productivity while at the same time reducing expenses. "The appeal of this delivery model is its immediate availability to Life Science companies of all sizes, and its ability to accommodate a wide range of the requirements needed to quickly and effectively deploy the software and get clinical studies up and running in weeks and not months," said Bob Borysko, DZS's VP of Product Development. "By improving global user accessibility and communications, tremendous efficiencies and time-savings can be realized, manual operations can be reduced and redundant data and tasks can be completely eliminated."
Because of the continuum of disparate functions and business units that typically exist across pharmaceutical companies, CROs and clinical trial sites, SaaS-enabled technologies have gained increased popularity of late because they can be implemented without IT department support, don't require significant up-front capital investment, and eliminate the need for installed servers and the associated maintenance costs. All that's required is an internet connection and browser.
According to Gartner Research, SaaS Delivery within the Enterprise Application Software markets will show consistent growth through 2013, with worldwide SaaS revenue totaling an estimated $14.4 billion based on total software revenue. In 2008 revenue was $6.4 billion.
Until recently, skeptics have been reluctant to adopt SaaS technology in part because of security concerns. However, using virtualization systems, DZS's SaaS model provides Life Science organizations a distinct and self-contained environment to maintain data protection. Data is also preserved through daily incremental backup and weekly full backup. Other benefits include the ability to scale up or down as needed; round-the-clock accessibility, and complete control over study timelines.
To speak to a product expert or a personalized demonstration, please contact sales&marketing@clinplus.com or follow this link to request specific information or pricing: http://www.clinplus.com/ctms-landing-clinplus-clinical-trial-management-system-ctms/?utm_campaign=CTMS-ACRP&utm_source=PR-Fastpitch%2C%20Group%20posts
About DZS Software Solutions, Inc.
DZS Software Solutions, Inc. (www.clinplus.com) is a privately held company founded in 1996 providing clinical trials software for clinical data management and analysis to the biotech and pharmaceutical industry worldwide. Over 50 clients globally presently use ClinPlus® software for data collection and capture, data cleansing, coding, analysis, clinical trial management and reporting. When the software is coupled with DZS services and training, many ClinPlus clients have dramatically improved productivity and maximized the value of clinical research investments and gained a competitive advantage to get medicines and products to market faster.
The ClinPlus® Software Solutions Suite for Clinical Trials provides premium tools required by pharmaceutical companies, contract research organizations (CROs), biotechs, and medical device manufacturers to expedite clinical trials and meet the strict data formatting requirements of the FDA and other global regulatory agencies.
The ClinPlus® Software Solutions Suite's unmatched cost-of-entry, scalability, flexible delivery options and exceptional training and support have gained DZS a reputation for delivering exacting quality and helping clients achieve early visibility to reliable clinical data. DZS software engineers possess decades of statistical analysis, clinical data management, clinical project management, and ADE/Drug coding and table/list/report building experience. This real-world experience is incorporated into every ClinPlus® system design and is evident in the reliability and enhanced features found every system!
Contact:
Keith W. Ward
Director of Global Marketing
DZS Software Solutions, Inc.
1661 Route 22 West,
Bound Brook, NJ 08805-1258
Office: (732) 764-6969 Ext: 129
Fax: (732) 764-6755
http://www.linkedin.com/profile
kward@clinplus.com
www.clinplus.com
Contact DZS Today!
